References
Becker, T. C.; Noel, R. J.; Coats, W. S., et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43:161–189; 1994.
Carmeliet, P.; Moons, L.; Herbert, J. M., et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81:829–839; 1997a.
Carmeliet, P.; Stassen, J. M.; Van Vlaenderen, I., et al. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood 90:1527–1534; 1997b.
Cornelius, L. A.; Nehring, L. C.; Roby, J. D., et al. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Investig. Dermatol. 105:170–176; 1995.
Dichek, D. A.; Anderson, J.; Kelly, A. B., et al. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 93:301–309; 1996.
Dollery, C. M.; McEwan, J. R.; Henney, A. M. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77:863–868; 1995.
Faraday, N.; Rade, J. J.; Johns, D. C., et al. Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression. Blood 94:4084–4092; 1999.
Guzman, R. J.; Hirschowitz, E. A.; Brody, S. L., et al. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 91:10,732–10,736; 1994.
Mawatari, M.; Okamura, K.; Matsuda, T., et al. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp. Cell Res. 192:574–580; 1991.
Mignatti, P.; Rifkin, D. B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117–137; 1996.
Mignatti, P.; Tsuboi, R.; Robbins, E., et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108:671–682; 1989.
Odekon, L. E.; Sato, Y.; Rifkin, D. B. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol. 150:258–263; 1992.
Reidy, M. A.; Irvin, C.; Lindner, V. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78:405–414; 1996.
Schnaper, H. W.; Barnathan, E. S.; Mazar, A., et al. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. J. Cell. Physiol. 165:107–118; 1995.
Schulick, A. H.; Dong, G.; Newman, K. D., et al. Endothelium-specific in vivo gene transfer. Circ. Res. 77:475–485; 1995.
Sepp, N. T.; Li, L. J.; Lee, K. H., et al. Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells. J. Investig. Dermatol. 103:295–299; 1994.
Welling, T. H.; Huber, T. S.; Messina, L. M., et al. Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism. J. Surg. Res. 66:36–42; 1996.
Wijnberg, M. J.; Quax, P. H.; Nieuwenbroek, N. M., et al. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thromb. Hemost. 78:880–886; 1997.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zablocki, D.K., Rade, J.J. & Alevriadou, B.R. Adenovirus-mediated expression of tissue plasminogen activator does not alter endothelial cell proliferation and invasion. In Vitro Cell.Dev.Biol.-Animal 36, 625–628 (2000). https://doi.org/10.1290/1071-2690(2000)036<0625:AMEOTP>2.0.CO;2
Received:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0625:AMEOTP>2.0.CO;2